Ardana Bioscience, Zentaris deal

Ardana paid E4.5 million ($4.4 million) for Zentaris' Europeptides subsidiary (Paris, France). Ardana gained global rights to Leuprorelin, a depot formulation of a LHRH agonist to treat prostate canc...